In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Santosh Prabhu, PhD, Divisional Vice President of Product Development for Abbott’s Structural Heart business, to discuss the company’s expanding portfolio and its impact on patients. Prabhu […]
In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the […]
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints […]
In this episode of AbbottTalks, we dive into the surprising origins of neuromodulation, kicking off with a shocker (literally)—treating headaches with electric fish. Neuromodulation expert Yagna Pathak, PhD, Medical Science Manager of Medical Affairs at Abbott’s Neuromodulation business, explains how […]
In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies. Overseeing product launches in over 100 countries, he discusses the deep need […]
AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott’s senior leaders. Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for […]
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his […]
In this episode of the DeviceTalks Weekly Podcast, Meghan Scanlon, SVP and president of urology at Boston Scientific, updates us on the integration of its powerhouse neurostim acquisition – Axonics. Scanlon also offers great insights on what makes the urology […]
In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA […]
We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of […]
Few technologies present the promise – and face the hurdles – of the neuromodulation industry. Unproven business models, intense clinical trials, and uncertain business models are just SOME of the challenges that have faced start-ups over the years. In neuromodulation, […]
In the newest episode of AbbottTalks, Allen Burton, Divisional VP and Chief Medical Officer of Neuromodulation at Abbott, shares insights into the company’s innovative neuromodulation therapies. Burton delves into Abbott’s FDA-approved treatment for chronic back pain, which uses electrical stimulation […]
